Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Mumps and Influenza Vaccine Co-administration in Junior High Students
NCT06208683Phase 4Active, not recruiting
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Nov 2023
- Primary completion
- Feb 2024
- Modality
- Live Attenuated Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of mumps vaccine, live in mumps, sponsored by Sinovac Biotech Ltd.. Started Nov 2023; status: active, not recruiting.
02
Drugs
mumps vaccine, live
03
Conditions
mumps
Beyond the preview
Go deeper on NCT06208683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06208683.